Targeting MAPK4 enzyme may provide therapy for prostate cancer

New York, Feb 21 (IANS) There is a possibility that targeting the enzyme MAPK4 in human prostate cancer might provide a novel therapeutic strategy for the disease, said researchers.The study indicate...

Become a proud member of 1947.com to access this content.